American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$272M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$237M |
| 3 |
Kenvue
KVUE
|
+$236M |
| 4 |
Norfolk Southern
NSC
|
+$219M |
| 5 |
Amazon
AMZN
|
+$173M |
Top Sells
| 1 |
Marvell Technology
MRVL
|
+$230M |
| 2 |
Walt Disney
DIS
|
+$193M |
| 3 |
Advanced Micro Devices
AMD
|
+$165M |
| 4 |
Johnson & Johnson
JNJ
|
+$153M |
| 5 |
MarketAxess Holdings
MKTX
|
+$148M |
Sector Composition
| 1 | Technology | 23.05% |
| 2 | Healthcare | 13.44% |
| 3 | Financials | 13.33% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Chegg
CHGG
$161M
| $186K | ﹤0.01% |
20,847
+5,786
| +38% | +$51.6K |
|
2577
Tarsus Pharmaceuticals
TARS
$2.07B
| $185K | ﹤0.01% |
10,427
-793
| -7% | -$14.1K |
|
2578
ThredUp
TDUP
$1.3B
| $182K | ﹤0.01% |
45,355
+15,644
| +53% | +$62.7K |
|
2579
Caribou Biosciences
CRBU
$168M
| $181K | ﹤0.01% |
37,802
+10,374
| +38% | +$49.6K |
|
2580
Alto Ingredients
ALTO
$91.3M
| $180K | ﹤0.01% |
40,726
+20,640
| +103% | +$91.2K |
|
2581
Concrete Pumping Holdings
BBCP
$364M
| $179K | ﹤0.01% |
+20,848
| New | +$179K |
|
2582
Lyell Immunopharma
LYEL
$251M
| $178K | ﹤0.01% |
6,048
+2,042
| +51% | +$60K |
|
|
SRG
2583
Seritage Growth Properties
SRG
$237M
| $178K | ﹤0.01% |
22,970
+8,612
| +60% | +$66.7K |
|
2584
PMV Pharmaceuticals
PMVP
$66.2M
| $177K | ﹤0.01% |
28,811
+8,146
| +39% | +$50K |
|
2585
Allogene Therapeutics
ALLO
$253M
| $176K | ﹤0.01% |
55,536
+12,380
| +29% | +$39.2K |
|
2586
Bit Digital
BTBT
$951M
| $174K | ﹤0.01% |
+81,534
| New | +$174K |
|
2587
Liberty Latin America Class A
LILA
$1.5B
| $170K | ﹤0.01% |
20,837
+5,831
| +39% | +$47.6K |
|
2588
Petco
WOOF
$978M
| $169K | ﹤0.01% |
41,381
+20,080
| +94% | +$82.1K |
|
2589
TaskUs
TASK
$1.57B
| $169K | ﹤0.01% |
16,290
+3,964
| +32% | +$41.1K |
|
2590
Atea Pharmaceuticals
AVIR
$248M
| $168K | ﹤0.01% |
55,893
+21,503
| +63% | +$64.5K |
|
2591
Fulcrum Therapeutics
FULC
$372M
| $164K | ﹤0.01% |
36,939
+8,522
| +30% | +$37.8K |
|
2592
Spirit AeroSystems
SPR
$4.57B
| $163K | ﹤0.01% |
10,129
| – | – |
|
2593
Limoneira
LMNR
$278M
| $163K | ﹤0.01% |
+10,664
| New | +$163K |
|
2594
Stitch Fix
SFIX
$724M
| $162K | ﹤0.01% |
46,929
+12,417
| +36% | +$42.8K |
|
2595
Zegna
ZGN
$2.22B
| $159K | ﹤0.01% |
11,413
-9
| -0.1% | -$125 |
|
|
CNSL
2596
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $158K | ﹤0.01% |
46,277
+16,488
| +55% | +$56.4K |
|
2597
Lifetime Brands
LCUT
$90M
| $158K | ﹤0.01% |
+28,094
| New | +$158K |
|
2598
SiriusXM
SIRI
$7.88B
| $158K | ﹤0.01% |
3,494
+479
| +16% | +$21.7K |
|
2599
Adtran
ADTN
$815M
| $157K | ﹤0.01% |
19,123
+4,673
| +32% | +$38.5K |
|
2600
Blue Foundry Bancorp
BLFY
$201M
| $155K | ﹤0.01% |
18,529
+3,431
| +23% | +$28.7K |
|